Camp4 Therapeutics Cash Flow Statement (2023-2026) | CAMP

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -12.40M-13.37M-13.58M-13.08M-23.77M-14.29M-13.65M-20.13M-14.10M-12.94M-12.22M
Share-based Compensation (Quarter) 0.72M-0.87M0.86M0.79M7.20M0.80M0.86M1.00M0.98M1.15M1.47M
Asset Writedowns and Impairment (Quarter) 0.49M-0.01M
Cash from Operations (Quarter) -11.78M-11.14M-13.44M-9.69M-11.29M-14.29M-10.34M-11.17M6.25M-10.98M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.40M0.43M0.45M0.46M0.47M0.48M0.49M0.48M0.03M
Depreciation & Amortization (CF) (Quarter) 0.43M0.44M0.42M0.42M0.42M0.42M0.43M0.42M0.37M0.52M
Change in Working Capital
Change in Account Payables (Quarter) -0.15M0.98M-1.04M1.08M-0.86M0.17M-0.19M-0.55M-0.47M0.59M
Change in Accured Expenses (Quarter) 0.56M0.45M-1.48M0.72M1.84M-2.79M1.03M1.36M1.20M-1.37M
Other Working Capital Changes (Quarter) 0.39M-0.39M17.50M-1.21M
Investing Activities
Capital Expenditures (Quarter) 0.62M0.15M0.03M0.26M0.28M
Cash from Investing Activities (Quarter) -0.24M-0.01M-0.16M-0.26M-0.28M0.04M
Financing Activities
Other financing activities (Quarter) 3.60M
Change in Capital Stock
Shares Issued (Quarter) 2.27M2.08M
Net Equity Issued and Repurchased (Quarter) -0.01M0.00M0.03M76.32M
Misc.
Cash from Financing Activities (Quarter) -0.06M-0.20M-0.81M-0.39M73.06M-0.15M0.07M47.38M28.59M0.06M
Change in Cash (Quarter) -12.09M-11.36M-14.41M-10.08M61.51M-14.72M-10.27M36.20M34.88M-10.92M
Free Cash Flow (Quarter) -12.40M-11.29M-13.46M-9.69M-11.55M-14.29M-10.62M-11.17M6.25M-10.98M
Net Cash Flow (Quarter) -12.09M-11.36M-14.41M-10.08M61.51M-14.72M-10.27M36.25M34.83M-10.92M